Enabling diagnostics that support improved therapeutic solutionshttps://www.jnj.com/about-jnj/jnj-cr...
Katherine leads a global, cross-functional patient engagement leadership team responsible for developing and driving Janssen patient engagement strategy and measuring progress over time. She and her team are focused on incorporating direct patient voice into core processes, including disease area strategies, product development, clinical plans, pre-approval access, supply chain decisions and commercial strategies.
Katherine has over 20 years of experience at Johnson & Johnson in sales, marketing, strategy and business development roles. Most recently, she served as global commercial vice president for a Janssen business developing pharmaceutical ingredients for pain. Prior to that, Katherine led a cross-functional team responsible for commercial assessments of licensing and acquisition opportunities for Janssen neuroscience. Katherine began her career in women’s health and has demonstrated success in launch, turnaround and mature businesses in a variety of disease areas. She has a passion for and track record of coaching and developing people.
Katherine holds a BS in Business/Marketing from the Kelley School of Business. She and her husband , three children and a dog and live in Pennsylvania.
4 of 4
The Patient Focused Medicines Development (PFMD) group, established in 2015, is an independent multinational coalition, managed by The Syner...
The Pledge to Patients is a tool for cultural change within the health care systems as well as the patient engagement landscape. As organisa...
We have developed an online tool to capture and map key information from PE initiatives across the globe. The maps will inform the developme...
Medicines are developed to improve the life of patients, which requires a deep understanding of their needs and priorities. These can be gai...
I will be a role model and leader for Janssen in listening to patients. My team and I will develop tools and processes to enable all teams to listen to patients and embed patient engagement into our culture as a way of working. I will attend a minimum of two activities every 6 months focused on listening to patients.Work in progress
Through our "Patient Voice Plans" program, we will modify clinical trials based on direct patient feedback to improve the patient experience.Work in progress
I will share with patients examples of what we have done differently, based on patient feedback.Work in progress